Glass House Brands Inc. (GLASF)
OTCMKTS · Delayed Price · Currency is USD
9.04
+0.04 (0.49%)
Jan 14, 2026, 4:00 PM EST
Glass House Brands Market Cap
Glass House Brands has a market cap or net worth of $742.36 million as of January 15, 2026. Its market cap has increased by 74.05% in one year.
Market Cap
742.36M
Enterprise Value
893.58M
Revenue
196.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$9.04
Market Cap Chart
Since July 18, 2019, Glass House Brands's market cap has increased from 430.12M to 742.36M, an increase of 72.59%. That is a compound annual growth rate of 8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 742.36M | 4.10% |
| Dec 31, 2025 | 713.12M | 60.28% |
| Dec 31, 2024 | 444.93M | 32.62% |
| Dec 29, 2023 | 335.49M | 156.56% |
| Dec 30, 2022 | 130.77M | -39.88% |
| Dec 31, 2021 | 217.50M | -57.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.56M |
| Elite Pharmaceuticals | 497.45M |
| Northwest Biotherapeutics | 421.34M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 342.70M |
| Silence Therapeutics | 278.68M |
| Vaxart | 191.98M |